Delgocitinib is a JAK inhibitor that blocks the activation of the JAK-STAT pathway which has been shown to play a key role in the pathophysiology of chronic inflammatory skin diseases.

When it comes to your baby’s delicate skin, especially on their face, finding the right moisturiser isn’t just a nice-to-have, it’s a must. Baby skin is thinner and more sensitive than adult skin, ...

Question: I have lots of moles on my arms and legs and they start off like an insect bite. It is the strangest thing. I notice that my 12-year-old daughter seems to be developing these also – she ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Becoming the first approved treatment for chronic hand eczema in the U.S., Leo Pharma A/S’s Anzupgo (delgocitinib) received ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

The topical JAK inhibitor is the first treatment approved specifically for adults with moderate-to-severe chronic hand eczema.

Here are some of the best credit cards for young adults, whether you’re totally new to using them, or you’re looking for something a little more rewarding than your starter card.